HIV/AIDS Treatment Guidelines Search Results| NIH

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Search Results 221 – 240 of 339

Drug-Drug Interactions: Protease Inhibitors and Other Drugs

Table 14. Antiretroviral Drug Use in Pregnant People With HIV: Pharmacokinetic and Toxicity Data in Human Pregnancy and Recommendations for Use in Pregnancy | Overview

Nucleoside and Nucleotide Analogue Reverse Transcriptase Inhibitors

Abacavir (Ziagen, ABC)

Drug-Drug Interactions: Non-Nucleoside Reverse Transcriptase Inhibitors and Other Drugs

Non-Nucleoside Reverse Transcriptase Inhibitors

Drug-Drug Interactions: Nucleoside Reverse Transcriptase Inhibitors and Other Drugs

Emtricitabine (Emtriva, FTC)

Doravirine (Pifeltro, DOR)

Study and Trial Names

Drug-Drug Interactions: Integrase Strand Transfer Inhibitors and Other Drugs

Protease Inhibitors

Efavirenz (EFV)

Lamivudine (Epivir, 3TC)

Etravirine (Intelence, ETR)

Entry and Attachment Inhibitors

Drug-Drug Interactions: CCR5 Antagonist and Other Drugs

Tenofovir Alafenamide (Vemlidy, TAF)

Atazanavir (Reyataz, ATV)

Darunavir (Prezista, DRV)